Nanosphere, Inc. (NSPH) Misses Q2 EPS by 1c; Cuts FY14 Revs Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Wall St futures tick higher as oil retreats ahead of inflation data
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Birkenstock surges on revenue beat, higher full-year outlook
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Nanosphere Announces Second Quarter Financial and Operating Results
August 6, 2014 4:01 PM EDTCorporate Highlights and Business Guidance:
Added 37 new Verigene® System customer placements Achieved Q2 2014 revenues of $2.7 million, a 44% increase over Q2 2013 Increased consumable sales by 108% from prior year 2013 Gross margin increased to 38% from 32% from prior year 2013 Received FDA clearance for bacterial targets on Verigene Enteric Pathogens Test, submitted application for viral targets Reset 2014 guidance to $14 million in revenue and 175 to 200 new customer placements; down from the previous guidance of $19 million to $21 million and approximately 200 new customer placementsNORTHBROOK, Ill., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:... More
